18F-Choline PET/CT or PET/MR and the evaluation of response to systemic therapy in prostate cancer: are we ready?

PURPOSE: During the last decade, [18F]F-choline positron emission tomography (PET) had a rising role in prostate cancer (PCa) imaging. However, despite auspicious premises, [18F]F-choline PET is not currently recommended for the evaluation of response to therapy assessment in PCa, mainly due to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Urso, Luca, Lancia, Federica, Ortolan, Naima, Frapoli, Marta, Rauso, Martina, Artioli, Paolo, Cittanti, Corrado, Uccelli, Licia, Frassoldati, Antonio, Evangelista, Laura, Bartolomei, Mirco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Pictorial Essay
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333077/
https://www.ncbi.nlm.nih.gov/pubmed/35919380
http://dx.doi.org/10.1007/s40336-022-00515-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333077/
https://www.ncbi.nlm.nih.gov/pubmed/35919380
http://dx.doi.org/10.1007/s40336-022-00515-7

Ejemplares similares